Current Trends in Biohumoral Screening for the Risk of Sudden Cardiac Death: A Systematic Review

• Published in: Medicina (Kaunas, Lithuania) Lithuania), 2024-02, Vol.60 (3), p.418
• Main Authors: Isailă, Oana-Maria, Moroianu, Lavinia-Alexandra, Hostiuc, Sorin
• Format: Article
• Language: English
• Subjects: Biomarkers; Biomarkers - blood; Cardiac arrest; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - diagnosis; Cardiovascular Diseases - mortality; Death, Sudden, Cardiac - epidemiology; Death, Sudden, Cardiac - etiology; Death, Sudden, Cardiac - prevention & control; Heart; Humans; Kinases; Lifesaving; Mass Screening - methods; Pathology; Risk Factors; screening; specificity; sudden cardiac death; Systematic Review; Type 2 diabetes
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina60030418

: Sudden cardiac death (SCD) represents a challenge to health systems globally and is met with increased frequency in the population. Over time, multiple screening methods have been proposed, including the analysis of various plasma biomarkers. This article aims to analyze for illustrative purposes the specialized literature in terms of current biomarkers and testing trends, in the case of cardiovascular diseases and implicitly sudden cardiac death. : In this regard, we searched the PubMed database from 2010 to the present time using the keywords "sudden cardiac death" and "biomarkers". The inclusion criteria were clinical trials that analyzed the effectiveness of screening methods in terms of biomarkers used in stratifying the risk of cardiac distress and/or sudden cardiac death. We excluded reviews, meta-analyses, and studies looking at the effectiveness of treatments. : An extended approach was found, through studies that brought to the forefront both classical markers analyzed by new, more performant methods, markers for other pathologies that also determined cardiovascular impact, non-specific molecules with effects on the cardiovascular system, and state-of-the-art markers, such as microRNA. Some molecules were analyzed simultaneously in certain groups of patients. : The observed current trend revealed the tendency to define the clinical-biological particularities of the person to be screened.